110 related articles for article (PubMed ID: 22199370)
1. Matrix metalloproteinase-2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats.
Castro MM; Cena J; Cho WJ; Walsh MP; Schulz R
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):662-8. PubMed ID: 22199370
[TBL] [Abstract][Full Text] [Related]
2. Smoothelin-B is not a target of matrix metalloproteinase (MMP)-2 in the vasculature of endotoxemic rats.
de Souza P; Mazzaron de Castro M; Goobie G; da Silva-Santos JE; Schulz R
Can J Physiol Pharmacol; 2014 Oct; 92(10):887-91. PubMed ID: 25272092
[TBL] [Abstract][Full Text] [Related]
3. Matrix Metalloproteinase-2 Activity is Associated with Divergent Regulation of Calponin-1 in Conductance and Resistance Arteries in Hypertension-induced Early Vascular Dysfunction and Remodelling.
Parente JM; Pereira CA; Oliveira-Paula GH; Tanus-Santos JE; Tostes RC; Castro MM
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):246-256. PubMed ID: 28374979
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.
Lalu MM; Cena J; Chowdhury R; Lam A; Schulz R
Br J Pharmacol; 2006 Sep; 149(1):31-42. PubMed ID: 16880766
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia.
Cena JJ; Lalu MM; Cho WJ; Chow AK; Bagdan ML; Daniel EE; Castro MM; Schulz R
Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H45-51. PubMed ID: 19837953
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dependence of matrix metalloproteinase-mediated vascular hyporeactivity caused by lipopolysaccharide.
Cena J; Lalu MM; Rosenfelt C; Schulz R
Eur J Pharmacol; 2008 Mar; 582(1-3):116-22. PubMed ID: 18242597
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension.
Blascke de Mello MM; Parente JM; Schulz R; Castro MM
Vascul Pharmacol; 2019 May; 116():36-44. PubMed ID: 30339939
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase (MMP)-2 decreases calponin-1 levels and contributes to arterial remodeling in early hypertension.
Belo VA; Parente JM; Tanus-Santos JE; Castro MM
Biochem Pharmacol; 2016 Oct; 118():50-58. PubMed ID: 27531060
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitors prevent sepsis-induced refractoriness to vasoconstrictors in the cecal ligation and puncture model in rats.
de Souza P; Schulz R; da Silva-Santos JE
Eur J Pharmacol; 2015 Oct; 765():164-70. PubMed ID: 26297976
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.
Chew DK; Conte MS; Khalil RA
J Vasc Surg; 2004 Nov; 40(5):1001-10. PubMed ID: 15557917
[TBL] [Abstract][Full Text] [Related]
11. Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta.
Farmer MR; Roberts RE; Gardiner SM; Ralevic V
J Pharmacol Exp Ther; 2003 Aug; 306(2):538-45. PubMed ID: 12730359
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-lβ induces migration of rat arterial smooth muscle cells through a mechanism involving increased matrix metalloproteinase-2 activity.
Wang Z; Kong L; Kang J; Vaughn DM; Bush GD; Walding AL; Grigorian AA; Robinson JS; Nakayama DK
J Surg Res; 2011 Aug; 169(2):328-36. PubMed ID: 20371087
[TBL] [Abstract][Full Text] [Related]
14. Plasma matrix metalloproteinase activity in horses after intravenous infusion of lipopolysaccharide and treatment with matrix metalloproteinase inhibitors.
Fugler LA; Eades SC; Moore RM; Koch CE; Keowen ML
Am J Vet Res; 2013 Mar; 74(3):473-80. PubMed ID: 23438126
[TBL] [Abstract][Full Text] [Related]
15. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure.
Grandas OH; Mountain DH; Kirkpatrick SS; Cassada DC; Stevens SL; Freeman MB; Goldman MH
J Vasc Surg; 2009 Jan; 49(1):185-91. PubMed ID: 18829229
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
Lalu MM; Gao CQ; Schulz R
Mol Cell Biochem; 2003 Sep; 251(1-2):61-6. PubMed ID: 14575305
[TBL] [Abstract][Full Text] [Related]
17. Type I collagen proteolysis by matrix metalloproteinase-2 contributes to focal adhesion kinase activation and vascular smooth muscle cell proliferation in the aorta in early hypertension.
de Oliveira Neves VG; Blascke de Mello MM; Rodrigues D; Pernomian L; de Oliveira IS; Parente JM; Arantes EC; Tostes RC; Castro MM
Vascul Pharmacol; 2023 Oct; 152():107211. PubMed ID: 37607602
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of caspase inhibitors on the activity of matrix metalloproteinase-2.
Castro MM; Fuah J; Ali M; Sung M; Schulz J; Kondo MY; Fan X; Holt A; Schulz R
Biochem Pharmacol; 2013 Aug; 86(4):469-75. PubMed ID: 23774623
[TBL] [Abstract][Full Text] [Related]
19. Effects of aminoguanidine and N(omega)-nitro-L-arginine methyl ester on vascular hyporeactivity induced by endotoxaemia.
Ismailoglu UB; Pekiner C; Yorganci K; Sahin-Erdemli I
Eur J Surg; 2001 Nov; 167(11):803-9. PubMed ID: 11848232
[TBL] [Abstract][Full Text] [Related]
20. [Melatonin improves vascular reactivity of endotoxemia rats].
Xing HY; Ling YL; Meng AH; Zhao XY; Huang XL
Sheng Li Xue Bao; 2005 Jun; 57(3):367-72. PubMed ID: 15968434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
